![]() |
|
|
Vol. 27, Issue 9, 1005-1009, September 1999
Departments of Pharmacology (J.H., G.C., J.M.F.) and Obstetrics and
Gynecology (G.C.), University of California at Los Angeles School of
Medicine, Center for the Health Sciences, Los Angeles, California
Nitric oxide (NO) is both an endogenously generated species and the
active species released from a variety of important drugs. Due to its
endogenous generation and use as a therapeutic agent, the metabolism
and fate of NO is of interest and concern. To date, most attention
regarding the metabolism and fate of NO has been paid to its oxidized
metabolites. Due to the reducing environment of cells, we considered
that NO may also undergo reductive metabolism as well. Therefore, we
have examined the reductive metabolism of NO by hepatocytes. Generation
of nitrous oxide (N2O) was used as an indication of NO
reduction. Indeed, we observed that NO could be reduced to
N2O by the cytosolic fraction of hepatocytes. The
N2O production was partially inhibited by the thiol
modifying agent, N-ethylmaleimide and thiol
consumption was observed during N2O formation. Thus, our
results indicate that NO reduction is feasible and likely occurs via a
thiol-dependent process.